Replies to post #5392 on Opko Health Inc (OPK)

[Sky10]

I did a rough calculation on the back of envelope : Assuming the Rayaldee prescriptions increasing 40% month to month ( which is very conservative due to the extra sales people they will hire ) then by Dec 2018 the revenues from Rayaldee will be $600 x 28,000= $ 16.8 M for Dec alone . So we can estimate the Rayaldee revenues for 2019 will be in the $ 250- $ 400 M range but in my opinion this is a very conservative estimation . Most likely the actual number will be in the $ 500 M -$ 750 M range .

I know that many get frustrated from the low price of OPK but in my opinion the worst is over . I wish I can buy more shares of OPK at this low price